SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000895421-24-000591
Filing Date
2024-11-07
Accepted
2024-11-07 17:37:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 MS AMENDMENT NurixTherapeuticsNRIX.txt SC 13G/A 10990
  Complete submission text file 0000895421-24-000591.txt   12910
Mailing Address 1585 BROADWAY NEW YORK NY 10036
Business Address 1585 BROADWAY NEW YORK NY 10036 212-761-4000
MORGAN STANLEY (Filed by) CIK: 0000895421 (see all company filings)

IRS No.: 363145972 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies
(CF Office: 02 Finance)

Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Subject) CIK: 0001549595 (see all company filings)

IRS No.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: SC 13G/A | Act: 34 | File No.: 005-91591 | Film No.: 241437313
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)